Skip to main content
ImmuneCited

[Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety].

Andreas Conrad, Herbert Kolodziej, Volker Schulz
Review Wiener medizinische Wochenschrift (1946) 2007 23 citations
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D17704982'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Type d'étude
Review
Population
None
Intervention
[Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety]. None
Comparateur
None
Critère de jugement principal
[Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and saf
Direction de l'effet
Mixed
Risque de biais
Unclear

Abstract

For centuries the roots of Pelargonium sidoides DC have been used in South African ethno-medicine for the treatment of respiratory diseases. In Germany, a medicinal product containing a special extract of this substance is among the group of self-medication products most widely bought at chemist's shops. In December 2005, the Federal Institute for Drugs and Medical Devices (BfArM, Bonn) approved a new license for its use as a drug. The following review focuses on the current pharmacological, toxicological and clinical data covering the efficacy and innocuousness of this drug when administered for the treatment of acute bronchitis.

En bref

The following review focuses on the current pharmacological, toxicological and clinical data covering the efficacy and innocuousness of this drug when administered for the treatment of acute bronchitis.

Used In Evidence Reviews

Similar Papers